Council for Responsible Nutrition
Home | Who is CRN? | About Dietary Supplements | Industry Regulation | Press Room | Annual Conference | Members Only

Legislation

DSHEA Summary and Analysis
Before and After DSHEA
Regulation
Food and Drug Administration (FDA) >
Federal Trade Commission (FTC)
Self-Regulation
Regulations at a Glance
CRN Comments
Federal Register Watch
International Policy
TransAtlantic Business Dialogue (TABD)
CODEX
Good Manufacturing Practices (GMPs)
• Joint Comments to FDA Docket # 96N-0417 on GMPs (CRN, AHPA and NNFA) (PDF) 01.30.04
• CRN Comments to FDA on GMPs with 4-way Comparison (PDF) 07.08.03

• CRN's Request to FDA for 120-Day Extension of Comment Period on GMPs (PDF)

• 4-way comparison chart (PDF)
Paul Bolar,vice president, regulatory and legal affairs for Pharmavite LLC and chairman of the CRN regulatory affairs committee, along with his staff at Pharmavite have prepared a side-by-side comparison of the new GMP proposal, the 1997 ANPR, the food GMPs and the drug GMPs.
• Dietary Supplement Industry to Review FDA's Proposed GMPs
• CRN's Fact Sheet on GMPs
1828 L Street, NW, Suite 510 • Washington, DC, 20036-5114 • (202) 204-7700 fax (202) 204-7701 • e-mail webmaster@crnusa.org